Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator

被引:125
|
作者
Curtis, Jeptha P. [1 ]
Luebbert, Jeffrey J. [6 ]
Wang, Yongfei [1 ]
Rathore, Saif S. [3 ]
Chen, Jersey [1 ]
Heidenreich, Paul A. [7 ]
Hammill, Stephen C. [8 ]
Lampert, Rachel I. [1 ]
Krumholz, Harlan M. [1 ,2 ,4 ,5 ]
机构
[1] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Sect Hlth Policy & Adm, Sch Publ Hlth, New Haven, CT 06520 USA
[5] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA
[6] Thomas Jefferson Univ, Sch Med, Dept Internal Med, Cardiol Sect, Philadelphia, PA 19107 USA
[7] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
[8] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA
来源
关键词
CARDIAC-RESYNCHRONIZATION THERAPY; MYOCARDIAL-INFARCTION; SURGEON SPECIALTY; COMPLICATIONS; MORTALITY; TRACK; RISK; CARE; ICD;
D O I
10.1001/jama.2009.547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Allowing nonelectrophysiologists to perform implantable cardioverter-defibrillator (ICD) procedures is controversial. However, it is not known whether outcomes of ICD implantation vary by physician specialty. Objective To determine the association of implanting physician certification with outcomes following ICD implantation. Design, Setting, and Patients Retrospective cohort study using cases submitted to the ICD Registry performed between January 2006 and June 2007. Patients were grouped by the certification status of the implanting physician into mutually exclusive categories: electrophysiologists, nonelectrophysiologist cardiologists, thoracic surgeons, and other specialists. Hierarchical logistic regression models were developed to determine the independent association of physician certification with outcomes. Main Outcome Measures In-hospital procedural complication rates and the proportion of patients meeting criteria for a defibrillator with cardiac resynchronization therapy (CRT-D) who received that device. Results Of 111 293 ICD implantations included in the analysis, 78 857 (70.9%) were performed by electrophysiologists, 24 399 (21.9%) by nonelectrophysiologist cardiologists, 1862 (1.7%) by thoracic surgeons, and 6175 (5.5%) by other specialists. Compared with patients whose ICD was implanted by electrophysiologists, patients whose ICD was implanted by either nonelectrophysiologist cardiologists or thoracic surgeons were at increased risk of complications in both unadjusted (electrophysiologists, 3.5% [2743/78 857]; nonelectrophysiologist cardiologists, 4.0% [970/24 399]; thoracic surgeons, 5.8% [108/1862]; P < .001) and adjusted analyses (relative risk [RR] for nonelectrophysiologist cardiologists, 1.11 [95% confidence interval {CI}, 1.01-1.21]; RR for thoracic surgeons, 1.44 [ 95% CI, 1.15-1.79]). Among 35 841 patients who met criteria for CRT-D, those whose ICD was implanted by physicians other than electrophysiologists were significantly less likely to receive a CRT-D device compared with patients whose ICD was implanted by an electrophysiologist in both unadjusted (electrophysiologists, 83.1% [21 303/25 635]; nonelectrophysiologist cardiologists, 75.8% [5950/7849]; thoracic surgeons, 57.8% [269/465]; other specialists, 74.8% [1416/1892]; P < .001) and adjusted analyses ( RR for nonelectrophysiologist cardiologists, 0.93 [95% CI, 0.91-0.95]; RR for thoracic surgeons, 0.81 [95% CI, 0.74-0.88]; RR for other specialists, 0.97 [95% CI, 0.94-0.99]). Conclusions In this registry, nonelectrophysiologists implanted 29% of ICDs. Overall, implantations by a nonelectrophysiologist were associated with a higher risk of procedural complications and lower likelihood of receiving a CRT-D device when indicated compared with patients whose ICD was implanted by an electrophysiologist.
引用
收藏
页码:1661 / 1670
页数:10
相关论文
共 50 条
  • [42] Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients
    Zhang, Yiyi
    Blasco-Colmenares, Elena
    Harms, Amy C.
    London, Barry
    Halder, Indrani
    Singh, Madhurmeet
    Dudley, Samuel C.
    Gutmann, Rebecca
    Guallar, Eliseo
    Hankemeier, Thomas
    Tomaselli, Gordon F.
    Cheng, Alan
    EUROPACE, 2016, 18 (09): : 1383 - 1390
  • [43] Discussions on Implantable Cardioverter-Defibrillator Deactivation in Patients Receiving Radiation Therapy: A Missed Opportunity
    Salum, Erik
    Turner, Suzette
    Syeda, Ambreen
    Singh, Sheldon M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (02) : 347 - 349
  • [44] Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention
    Khazanie, Prateeti
    Hellkamp, Anne S.
    Fonarow, Gregg C.
    Bhatt, Deepak L.
    Masoudi, Frederick A.
    Anstrom, Kevin J.
    Heidenreich, Paul A.
    Yancy, Clyde W.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Al-Khatib, Sana M.
    Journal of the American Heart Association, 2015, 4 (08): : e002061
  • [45] Successful extravascular implantable cardioverter-defibrillator implantation in a patient with recurrent transvenous implantable cardioverter-defibrillator erosion
    Robinson, Andrea
    Billakanty, Sreedhar
    Fu, Eugene
    Amin, Anish
    HEART RHYTHM O2, 2024, 5 (04): : 243 - 245
  • [46] Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention
    Ascoeta, Maria Soledad
    Marijon, Eloi
    Defaye, Pascal
    Klug, Didier
    Beganton, Frankie
    Perier, Marie-Cecile
    Gras, Daniel
    Algalarrondo, Vincent
    Deharo, Jean-Claude
    Leclercq, Christophe
    Fauchier, Laurent
    Babuty, Dominique
    Bordachar, Pierre
    Sadoul, Nicolas
    Boveda, Serge
    Piot, Olivier
    HEART RHYTHM, 2016, 13 (05) : 1045 - 1051
  • [47] Pacemaker/implantable cardioverter-defibrillator problem: Right ventricular lead missensing in a biventricular implantable cardioverter-defibrillator
    Otten, Richard F.
    Foreman, Lynne D.
    Groh, William J.
    HEART RHYTHM, 2008, 5 (01) : 158 - 159
  • [48] Celivarone in patients with an implantable cardioverter-defibrillator: Adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions
    Gojkovic, Olivera
    Aliot, Etienne M.
    Capucci, Alessandro
    Connolly, Stuart J.
    Crijns, Harry
    Hohnloser, Stefan H.
    Kulakowski, Piotr
    Roy, Denis
    Radzik, David
    Singh, Bramah N.
    Kowey, Peter R.
    HEART RHYTHM, 2012, 9 (02) : 217 - U2
  • [49] Shared decision making in implantable cardioverter-defibrillator patients
    Yilmaz, D.
    Egorova, A.
    Lensvelt, L. M. H.
    Van Erven, L.
    EUROPEAN HEART JOURNAL, 2020, 41 : 782 - 782
  • [50] Exercise and competitive sports in patients with an implantable cardioverter-defibrillator
    Heidbuchel, Hein
    Carre, Francois
    EUROPEAN HEART JOURNAL, 2014, 35 (44) : 3097 - 3102